Synthesis demonstrates new bufadienolide compounds in targeted natural product exploration, suggesting efficient pathways.
In this work, we describe the synthesis of three new bufadienolide natural products cinobufotalin, bufotalin, and 5β-hydroxybufotalin and four new analogs of resibufogenin, bufalin, telocinobufagin, and marinobufogenin. This was achieved by developing a unified pathway that features installation of the characteristic α-pyrone ring onto steroid scaffolds with or without C5 oxygenation, and introduction of D-ring oxidation through a photochemical singlet oxygen [4 + 2] cycloaddition/endoperoxide rearrangement to furnish 14β,16β-bis-epoxides. Following a regioselective scandium(III) trifluoromethanesulfonate-catalyzed House–Meinwald rearrangement previously used to synthesize cinobufagin, these intermediates were elaborated to, cinobufotalin (13 steps LLS, 8.0% yield), bufotalin (12 steps LLS, 5.9% yield), and 5β-hydroxybufotalin (14 steps, 1.3% yield). This strategy was further extended to access new analogs of resibufogenin (26), bufalin (25), telocinobufagin (30), and marinobufogenin (29). Altogether, these studies describe the development of a general platform for accessing natural and unnatural bufadienolides from readily available androstenedione 5.
No takes yet. Share an insight, caveat, or question.
Tichvon et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: